Clinical Trials Logo

Clinical Trial Summary

The goal of this research study is to create an internet-based program designed to improve the communication of health and health history information among family members affected by Lynch syndrome.


Clinical Trial Description

If you agree to take part in this study, you will be assigned to 1 of 3 groups based on when you joined the study.

Group 1:

If you are assigned to Group 1, you will take part in a focus group where you will be asked what you would want in a web-based program designed to improve the communication of health and health history information among family members affected by Lynch syndrome. You will also fill out a questionnaire with questions about your demographics (age, race, marital status) and your medical history. This visit should take about 1 hour to complete.

Group 2:

If you are assigned to Group 2, you will come to the Behavioral Research and Treatment Center (BRTC) at MD Anderson to use the initial version of the My Family Garden website. My Family Garden is designed to teach new ways of communicating about Lynch Syndrome and about other issues related to the disease (such as risks associated with the disease, etc.). You will be instructed on how to use the program by the study staff. After you use the website, you will have an interview where you will provide feedback on your session. You will be asked questions about your feelings about the website and about any possible improvements that could be made to the website. You will also fill out a questionnaire called the Website Analysis and MeasureMent Inventory (WAMMI) which is designed help rate websites. You will also fill out the demographics questionnaire described above.

You will be given the option of completing the WAMMI and demographics questionnaire at the BRTC after your session or at your home. If you choose to complete them at home, you will be provided with a self-addressed, postage-paid envelope so you can mail the questionnaires back to the study staff.

This visit should take about 90 minutes to complete.

Group 3:

If you are assigned to Group 3, you will use the final version of the My Family Garden website. This final version will include changes from the web designers after feedback has been given from the previous groups in this study.

After you use the website, you will have an interview where you will provide feedback on your session. You will be asked questions about your feelings about the website and about any possible improvements that could be made to the website. You will also fill out the WAMMI questionnaire and demographics questionnaire described above.

You will be given the option of coming to the BRTC at MD Anderson to use the My Family Garden computer program or using the program from your home. If you choose to use My Family Garden from your home, you will be given a secure, password-protected hyperlink via e-mail to access the program. You will be instructed on how to use the program by the study staff either in person or over the phone. If you use the program from your home, the study staff will give the interview over the phone. If you complete the questionnaire at your home, you will be provided with a self-addressed, postage-paid envelope so you can mail it back to the study staff.

Whether it is completed at MD Anderson or at home, this visit should last about 90 minutes.

Audiotapes:

All focus groups and interviews will be audiotaped. The audiotapes collected during the course of this study will be stored in locked file cabinets in a locked office and will be destroyed after 5 years.

Length of Study Participation:

Your participation in this study will be over after you have completed the study procedures described above.

This is an investigational study.

Up to 49 participants will be enrolled in this study. All participants will be enrolled at MD Anderson. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01645904
Study type Observational
Source M.D. Anderson Cancer Center
Contact
Status Active, not recruiting
Phase
Start date February 2013
Completion date February 2021

See also
  Status Clinical Trial Phase
Recruiting NCT05358964 - Family Health Histories: Creating a Culturally Tailored Tool to Reduce Health Disparities in the Black Community N/A
Recruiting NCT06183138 - Multicenter Analysis of Genomic and Metabolic Data of Neonatal Genetic Diseases
Recruiting NCT06107400 - Safety and Efficacy of RM-004 Cells for Hemoglobin H-Constant Spring Disease Early Phase 1
Completed NCT00001466 - Study of Clinical and Molecular Manifestations of Genetic Disorders N/A
Active, not recruiting NCT04428710 - Assessment Psychological Distress for Cancer Heredity Test
Recruiting NCT04531696 - UZ/KU Leuven Program for Post-mortem Tissue Donation to Enhance Research N/A
Completed NCT01343953 - Cord Blood Transplantation in Severe Aplastic Anemia Phase 2
Enrolling by invitation NCT05721326 - Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition N/A
Enrolling by invitation NCT04548921 - Biomarker for Friedreich's Ataxia (BioFridA)
Recruiting NCT06330441 - Pancreatic Cancer Screening in a Population at High Risk N/A
Completed NCT02416440 - Durban Diabetes Study:A Study of the Epidemiology of Diabetes Mellitus in Urban South Africans of African Descent (DDS) Phase 0
Recruiting NCT05587439 - Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
Withdrawn NCT04531878 - BSEP Function Rescue During Childhood Inhereditary Cholestatic Diseases Phase 2/Phase 3
Completed NCT02917070 - Parental Consanguinity and Family History of Kidney Disease in Turkish Kidney Disease Population N/A
Recruiting NCT05161169 - Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants N/A
Recruiting NCT06157983 - Evaluation of Cascade Screening for Elevated Lipoprotein(a)
Active, not recruiting NCT04528498 - Embryo Health Study
Completed NCT05453474 - Cell-based Non-invasive Prenatal Testing as an Alternative to Invasive Chorionic Villus Sampling N/A
Terminated NCT00314691 - Development of New Prenatal Diagnostic Tests From Maternal Blood N/A